ArticleBreast (Edinburgh, Scotland)2025

Baseline neutrophil-lymphocyte ratio (NLR) predicts toxicity and survival in HR+/HER-2 breast cancer patients treated with CDK4/6 inhibitors.

Omar Badran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.